It's not all about the virus-On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B

Mathias Jachs¹, Hans L Tillmann^{2

3}

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine III , Medical University of Vienna , Vienna , Austria.
² Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Brody School of Medicine , East Carolina University , Greenville , North Carolina , USA.
³ Greenville VA Health Care Center , Greenville , North Carolina , USA.

Editorial

Mathias Jachs et al. Hepatology. 2023.

. 2023 Feb 1;77(2):352-354.

doi: 10.1002/hep.32798. Epub 2022 Oct 11.

Mathias Jachs¹, Hans L Tillmann^{2

3}

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine III , Medical University of Vienna , Vienna , Austria.
² Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Brody School of Medicine , East Carolina University , Greenville , North Carolina , USA.
³ Greenville VA Health Care Center , Greenville , North Carolina , USA.

No abstract available

Comment on

Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes.
Mak LY, Hui RW, Lee CH, Mao X, Cheung KS, Wong DK, Lui DT, Fung J, Yuen MF, Seto WK. Mak LY, et al. Hepatology. 2023 Feb 1;77(2):606-618. doi: 10.1002/hep.32716. Epub 2022 Sep 21. Hepatology. 2023. PMID: 36130882

1. Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol. 2015;62:956–67.
1. Lange NF, Radu P, Dufour JF. Prevention of NAFLD‐associated HCC: role of lifestyle and chemoprevention. J Hepatol. 2021;75:1217–27.
1. Mak LY, Hui RWH, Lee CH, Mao X, Cheung KS, Wong DKH, et al. Glycemic burden and the risk of adverse hepatic outcomes in chronic hepatitis B patients with type 2 diabetes. Hepatology. 2023;77:606–18.
1. Hosokawa T, Kurosaki M, Tsuchiya K, Matsuda S, Muraoka M, Suzuki Y, et al. Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy. World J Gastroenterol. 2013;19:249–57.
1. Marti‐Aguado D, Clemente‐Sanchez A, Bataller R. Cigarette smoking and liver diseases. J Hepatol. 2022;77:191–205.